M^T Bank Corporation »

Aclaris Therapeutics shares owned by M^T Bank Corporation

Quarter-by-quarter ownership of Aclaris Therapeutics (ACRS) shares owned by M^T Bank Corporation from 13F filings

Historical chart of M^T Bank Corporation investment in Aclaris Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aclaris Therapeutics held by M^T Bank Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aclaris Therapeutics by M^T Bank Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $38k 10k 3.75

More positions owned by M^T Bank Corporation

Ishares Tr Core Msci Eafe (IEFA)
Apple (AAPL)
Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Rus 1000 Val Etf (IWD)
Microsoft Corporation (MSFT)
Ishares Core Msci Emkt (IEMG)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl C (GOOG)
Ishares Tr Msci Usa Qlt Fct (QUAL)
JPMorgan Chase & Co. (JPM)
Ishares Tr Russell 2000 Etf (IWM)
Broadcom (AVGO)
Ishares Tr S&p 500 Grwt Etf (IVW)

View all positions for M^T Bank Corporation

Top funds holding Aclaris Therapeutics

BML Capital Management
Deep Track Capital
BlackRock
RA Capital Management
Vivo Capital
Vanguard Group
Vanguard Capital Management
Frazier Life Sciences Management
Rock Springs Capital Management
Decheng Capital
Adage Capital Partners GP
Balyasny Asset Management
Citadel Advisors
Morgan Stanley
Geode Capital Management

View all funds holding Aclaris Therapeutics